tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BIIB Stock Latest News

Jefferies sees Akero, Scholar Rock as ‘promising’ takeover targets
The FlyJefferies sees Akero, Scholar Rock as ‘promising’ takeover targets
23h ago
LLY
MRK
Biogen’s Felzartamab: A Promising Blockbuster Potential in Antibody-Mediated Conditions
PremiumRatings
Biogen’s Felzartamab: A Promising Blockbuster Potential in Antibody-Mediated Conditions
1d ago
BIIB
Biogen’s Long-Term Potential Overshadowed by Near-Term Challenges: Hold Rating Justified
PremiumRatings
Biogen’s Long-Term Potential Overshadowed by Near-Term Challenges: Hold Rating Justified
2d ago
BIIB
Biogen, UCB present results from Phase 3 PHOENYCS GO study of DZP
PremiumThe Fly
Biogen, UCB present results from Phase 3 PHOENYCS GO study of DZP
2d ago
BIIB
Biogen’s Hold Rating: Navigating Opportunities and Challenges in Clinical Developments
PremiumRatings
Biogen’s Hold Rating: Navigating Opportunities and Challenges in Clinical Developments
2d ago
BIIB
Biogen presents additional results from PHOENYCS GO study
PremiumThe FlyBiogen presents additional results from PHOENYCS GO study
2d ago
BIIB
Biogen’s Strategic Advancements in Autoimmune Sector Drive Buy Rating
Premium
Ratings
Biogen’s Strategic Advancements in Autoimmune Sector Drive Buy Rating
3d ago
BIIB
Biogen highlights potential of felzartamab
Premium
The Fly
Biogen highlights potential of felzartamab
3d ago
BIIB
Biogen’s Strategic Growth and Diversification Drive Buy Rating
PremiumRatings
Biogen’s Strategic Growth and Diversification Drive Buy Rating
3d ago
BIIB
Biogen’s Strategic Collaboration with City Therapeutics: A Buy Rating for Long-term Growth in RNAi Therapeutics
PremiumRatings
Biogen’s Strategic Collaboration with City Therapeutics: A Buy Rating for Long-term Growth in RNAi Therapeutics
18d ago
BIIB
Biogen, City Therapeutics announce strategic research collaboration
PremiumThe Fly
Biogen, City Therapeutics announce strategic research collaboration
18d ago
BIIB
SPY ETF News, 5/15/2025
PremiumMarket News
SPY ETF News, 5/15/2025
1M ago
ARE
BEN
VOO ETF News, 5/15/2025
PremiumMarket NewsVOO ETF News, 5/15/2025
1M ago
ARE
BEN
Biogen Completes $1.75 Billion Notes Issuance
Premium
Company Announcements
Biogen Completes $1.75 Billion Notes Issuance
1M ago
8K
BIIB
Denali Therapeutics price target lowered to $30 from $32 at Wedbush
Premium
The Fly
Denali Therapeutics price target lowered to $30 from $32 at Wedbush
1M ago
BIIB
DNLI
Biogen price target lowered to $169 from $207 at Mizuho
PremiumThe Fly
Biogen price target lowered to $169 from $207 at Mizuho
1M ago
BIIB
Biogen price target lowered to $175 from $185 at JPMorgan
PremiumThe Fly
Biogen price target lowered to $175 from $185 at JPMorgan
1M ago
BIIB
Biogen’s Hold Rating: Balancing New Drug Growth with Declining MS Franchise and Safety Concerns
PremiumRatings
Biogen’s Hold Rating: Balancing New Drug Growth with Declining MS Franchise and Safety Concerns
1M ago
BIIB
Biogen’s International Growth and Promising Pipeline Drive Buy Rating
PremiumRatings
Biogen’s International Growth and Promising Pipeline Drive Buy Rating
1M ago
BIIB
Biogen price target lowered to $205 from $255 at Oppenheimer
PremiumThe FlyBiogen price target lowered to $205 from $255 at Oppenheimer
1M ago
BIIB
Biogen price target lowered to $205 from $217 at RBC Capital
Premium
The Fly
Biogen price target lowered to $205 from $217 at RBC Capital
1M ago
BIIB
Biogen price target lowered to $146 from $152 at Morgan Stanley
Premium
The Fly
Biogen price target lowered to $146 from $152 at Morgan Stanley
1M ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >